[1]
Skibicka, K. et al. 2025. New Pharmacologic Approaches in Hypertension: Baxdrostat and Zilebesiran with Insights from BaxHTN and KARDIA-3 Trials. Journal of Education, Health and Sport. 84, (Sep. 2025), 65430. DOI:https://doi.org/10.12775/JEHS.2025.84.65430.